Carpet is a key decorative element and provides the foundation for decorating through the use of color and texture. Recently the carpet industry has lost market share in commercial settings due to perceived relationships between carpeted areas and an increase in illness, asthma, and allergies. The use of soft floor coverings in schools, hospitals, and other healthcare facilities has long been controversial as the carpet is thought to contribute to the presence of microorganisms in the indoor environment. Indoor air is a complex mixture of bioaerosols and non-biological particles. Among the most important of these are human and animal occupants that shed skin scales and other fragments, mold spores, viruses, and bacteria. Two types of antimicrobial treatments exist for carpets and coatings. The first type is used in the manufacturing process to prevent bacterial spoilage of latex compounds prior to the use in the manufacturing process. The other type of treatment is an antimicrobial additive incorporated in a treatment of the carpet fibers or into the backing structure of the carpet during manufacture. The intended purpose of these treatments is to provide protection, primarily against mold, when the soiled carpet is exposed to elevated moisture conditions.
This product is an antibacterial carpet.
This product is a carpet containing ZnO nanoparticles. The concentration of ZnO is 398 ppm in it. It also shows antibacterial activity compatible with INSO 11070.
In nano-scale, ZnO particles produce the reactive oxygen species more than ZnO bulk and so higher antibacterial activity appears in ZnO nanoparticles.
Use the brochure.
It should be noted that there are limited investigations on the safety of nanoproducts because of their new history. It is packed with polymeric films.
Standard Date : 2017/08/26
Expire Date : 2018/08/26